Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Dec 4, 2014
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-12-02+50,870→ 50,870 totalExercise: $17.76Exp: 2024-12-01→ Common Stock (50,870 underlying)
Footnotes (1)
- [F1]25% of the shares will vest on January 1, 2016 and the remainder of the shares will vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2019.